Pricing Log in Create free account
Saturday 17 October 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.95 0.76 +0.52%
Market cap
$358.2B
P/E
117×
Fwd P/E
53.9×
Dividend yield
2.33%
F-score
4/9
Altman Z
3.77
Beneish M
−2.27
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Merck & Co., Inc. (MRK) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Merck & Co., Inc. (MRK) trades at a P/B ratio of 8.6×. Over the past ten years it has ranged from 2.8× (September 2015) to 9.2× (August 2026); the current reading is higher than 99% of that period. That is above the Drug Manufacturers General industry median of 5.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 5.0× (7.93%)
FY2024 5.4× (28.84%)
FY2023 7.6× 24.94%
FY2022 6.1× 20.55%
FY2021 5.1× (34.80%)
FY2020 7.8× (9.20%)
FY2019 8.6× 18.48%
FY2018 7.2× 70.54%
FY2017 4.2× 7.57%
FY2016 3.9× 24.24%

Quarterly newest first

Period P/B ratio Change
Jun 2026 7.6× 16.77%
Mar 2026 6.5× 29.45%
Dec 2025 5.0× 23.97%
Sep 2025 4.0× (0.39%)
42 more quarters

Against its own ten years

Low 2.8× High 9.2×
Ten-year median 5.6×
Current reading's percentile 99

P/B ratio against peers

Company P/B ratio
ABBV AbbVie Inc. compare n/m
PFE Pfizer Inc. compare 2.0×
NVO Novo Nordisk A/S compare 5.0×
AZN AstraZeneca PLC compare 5.1×
NVS Novartis AG compare 6.8×
JNJ Johnson & Johnson compare 7.2×
MRK Merck & Co., Inc. 8.6×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. compare 20.0×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on MRK